About: Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients
Creator	Botas, · Cantador, Estefanía Espejo, Victoria Lucía Fabia, · Luis De Benito, · Núñez, Alberto Sobrino, · Vela, Lydia
Source	Medline; PMC
abstract	A high incidence of thrombotic events, particularly deep vein thrombosis and pulmonary embolism, has been clearly documented in COVID-19 patients. In addition, small series of patients with coronary, cerebrovascular and peripheral arterial thrombotic events have also been reported, but their true incidence and consequences are not well described, and constitute the objective of this study. From February 1st to April 21st, 2020, 2115 COVID-19 patients were treated at Hospital Universitario Fundación Alcorcón (Madrid, Spain), and 1419 were eventually admitted. Patient characteristics and outcomes were collected by reviewing their electronic medical records. Fourteen patients had a systemic arterial thrombotic event, which represents a 1% incidence in relation to the total number of hospitalized patients. Three patients suffered an acute coronary syndrome, two with persistent ST-segment elevation, one of whom was treated invasively, and one with transient ST-segment elevation. Eight patients had a cerebrovascular event. Six suffered an acute ischemic stroke and two a transient ischemic attack, 50% of them had a Rankin score ≥ 3 at discharge. Three additional patients had a limb thrombotic event, all of them infrapopliteal, and were managed conservatively. All three cases developed necrosis of the toes, two of them with bilateral involvement. The hospitalization death rate of patients with an arterial event was 28.6%. Although COVID-19 may favor the occurrence of thrombotic events, the destabilization and thrombosis of arterial atherosclerotic plaques do not seem to be a frequent mechanism which warrants the need for specific systematic preventive measures.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.1007/s11239-020-02176-7
bibo:pmid	32519165
has license	no-cc
sha1sum (hex)	59595032c56fc86c74a886f7d233f807e32b03d4
schema:url	https://doi.org/10.1007/s11239-020-02176-7
resource representing a document's title	Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients
has PubMed Central identifier	PMC7282535
has PubMed identifier	32519165
schema:publication	J Thromb Thrombolysis
resource representing a document's body	covid:59595032c56fc86c74a886f7d233f807e32b03d4#body_text
is schema:about of	named entity 'series' named entity 'number' named entity 'thrombotic' named entity 'patients' named entity 'patients' named entity 'thrombosis' named entity 'elevation' named entity 'addition' named entity 'necrosis' named entity 'Three' named entity 'documented' named entity 'thrombotic' named entity 'RANKIN' named entity 'OBJECTIVE' named entity 'TRANSIENT' named entity 'SMALL' named entity 'SERIES' named entity 'APRIL' named entity 'SYSTEMIC' covid:arg/59595032c56fc86c74a886f7d233f807e32b03d4 named entity 'arterial' named entity 'collected' named entity 'additional' named entity 'events' named entity 'arterial' named entity 'hospitalized' named entity 'embolism' named entity 'mechanism' named entity 'preventive' named entity 'COVID-19' named entity 'study' named entity 'limb' named entity 'thrombotic' named entity 'death rate' named entity 'April' named entity 'Hospital Universitario Fundación Alcorcón' named entity 'atherosclerotic plaques' named entity 'acute coronary syndrome' named entity 'cerebrovascular' named entity 'death rate' named entity 'acute ischemic stroke' named entity 'electronic medical records' named entity 'Eight' named entity 'edoxaban' named entity 'arterial thrombosis' named entity '8 days' named entity 'coronary disease' named entity 'invasive mechanical ventilation' named entity 'cardiovascular risk factors' named entity 'antithrombotic' named entity 'lung cancer' named entity 'hemodynamic' named entity 'ST elevation' named entity 'cardiac involvement' named entity 'circumflex' named entity 'COVID-19' named entity 'respiratory infections' named entity 'Vascular events' named entity 'sudden death' named entity 'infection' named entity 'bilateral pneumonia' named entity 'COVID-19' named entity 'cerebral hemorrhage' named entity 'Spain' named entity 'infection' named entity 'anticoagulation' named entity 'Neurology' named entity 'Severe Acute Respiratory Syndrome Coronavirus 2' named entity 'infarction' named entity 'COVID-19' named entity 'atherosclerotic plaques' named entity 'thrombotic events' named entity 'acute respiratory distress' named entity 'thrombotic events'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software